Merit Medical Systems (MMSI) Projected to Post Quarterly Earnings on Tuesday

Merit Medical Systems (NASDAQ:MMSI) is expected to issue its quarterly earnings data after the market closes on Tuesday, February 25th. Analysts expect the company to announce earnings of $0.82 per share and revenue of $351.54 million for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

Merit Medical Systems Stock Down 2.4 %

Shares of MMSI opened at $103.16 on Friday. The company has a market cap of $6.01 billion, a PE ratio of 50.57, a P/E/G ratio of 2.34 and a beta of 0.87. The business has a fifty day moving average of $102.64 and a 200 day moving average of $99.57. Merit Medical Systems has a 52-week low of $70.70 and a 52-week high of $111.45. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on MMSI. Robert W. Baird lifted their target price on Merit Medical Systems from $107.00 to $109.00 and gave the stock an “outperform” rating in a research report on Thursday, October 31st. StockNews.com downgraded Merit Medical Systems from a “buy” rating to a “hold” rating in a research report on Sunday, November 3rd. Canaccord Genuity Group lifted their target price on Merit Medical Systems from $127.00 to $128.00 and gave the stock a “buy” rating in a research report on Wednesday, January 29th. Barrington Research lifted their price target on shares of Merit Medical Systems from $114.00 to $115.00 and gave the company an “outperform” rating in a research note on Wednesday, January 29th. Finally, Needham & Company LLC increased their price objective on Merit Medical Systems from $109.00 to $122.00 and gave the stock a “buy” rating in a research note on Wednesday, January 29th. Two investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Merit Medical Systems currently has an average rating of “Moderate Buy” and an average target price of $109.80.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.